Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Checkpoint blockade with antibodies specific for cytotoxic T lymphocyte-associated protein (CTLA)-4 or programmed cell death 1 (PDCD1; also known as PD-1) elicits durable tumor regression in metastatic cancer, but these dramatic responses are confined to a minority of patients. This suboptimal outco...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | , , , , , , |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2017-06-13T18:03:16Z.
|
Subjects: | |
Online Access: | Get fulltext |